The Latest Cardiac and Vascular News
ENGLEWOOD CLIFFS, N.J., Jan. 13, 2025 /PRNewswire/ — BRAIN.Q, is excited to announce the CE Mark for its BQ 2.0 system, designed to reduce disability following ischemic stroke, the number one cause of disability worldwide. Reducing stroke disability is often achieved through endovascular…
SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ — Piccolo Medical®, an emerging leader in catheter navigation devices for vascular access procedures, is proud to announce an exclusive distribution agreement with Spectrum Vascular™, a leading provider of vascular access and medication…
MIAMI–(BUSINESS WIRE)–Jan. 10, 2025– Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced the appointment of Paul A. LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. “We are thrilled to have Paul assume […]
MINNEAPOLIS & WASHINGTON–(BUSINESS WIRE)–Vensana Capital today announced the closing of Vensana Capital III with $425 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s existing limited partners alongside select new institutional investors, and it brings Vensana’s total capital under management to […]
BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced the addition of two seasoned executives to its leadership team. Brad Davis has been named Chief Commercial Officer (CCO), and Bill Kelly has been named Chief […]
New York, January 9, 2025: The world’s most adopted healthcare AI company, Qure.ai, has appointed a new Chief Commercial Officer to oversee and expand global sales and business development strategy. Based in New York, Jim Mercadante joins a growing commercial and operations team to consolidate growing momentum and orchestrate further […]
LONG BEACH, Calif., Jan. 9, 2025 /PRNewswire/ — Christina Rodriguez, M.D., has been named medical director of advanced cardiac imaging at MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Dr. Rodriguez is a fellowship-trained, board-certified, non-invasive…
orthStar to support the development of YAP Therapeutics’ innovative radiolabeled products This collaboration merges the expertise and resources from both companies, including NorthStar’s state-of-the-art facilities The agreement guarantees that YAP Therapeutics will receive clinical trial-ready doses of its novel products in development January 08, 2025 08:01 AM Eastern Standard Time […]
Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]
BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently […]
